Lumos Pharma Inc (LUMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -53,595 | -71,951 | -71,951 | -40,381 | 96,017 |
| Depreciation Amortization | 1,145 | 1,407 | 1,407 | 1,592 | 1,097 |
| Accounts payable and accrued liabilities | -13,029 | -15,469 | -15,469 | 245 | 7,898 |
| Other Working Capital | -2,711 | 3,629 | 3,629 | -1,238 | 3,341 |
| Other Operating Activity | 30,251 | 34,103 | 34,103 | 15,695 | 715 |
| Operating Cash Flow | $-37,939 | $-48,281 | $-48,281 | $-24,087 | $109,068 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 10,213 | N/A |
| PPE Investments | 117 | 211 | 211 | -3,995 | -1,700 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -12,144 |
| Investing Cash Flow | $117 | $211 | $211 | $6,218 | $-13,844 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 97 |
| Debt Repayment | -167 | -246 | -246 | -194 | -187 |
| Common Stock Issued | 294 | 75,823 | 75,823 | 17,740 | 29,899 |
| Common Stock Repurchased | -275 | -289 | -289 | -561 | -222 |
| Other Financing Activity | 0 | 0 | 0 | 6,100 | 4,302 |
| Financing Cash Flow | $-148 | $75,288 | $75,288 | $23,085 | $33,889 |
| Beginning Cash Position | 158,708 | 131,490 | 131,490 | 190,404 | 61,291 |
| End Cash Position | 120,738 | 158,708 | 158,708 | 195,620 | 190,404 |
| Net Cash Flow | $-37,970 | $27,218 | $27,218 | $5,216 | $129,113 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,939 | -48,281 | -48,281 | -24,087 | 109,068 |
| Capital Expenditure | -7 | -43 | -43 | -3,995 | -1,700 |
| Free Cash Flow | -37,946 | -48,324 | -48,324 | -28,082 | 107,368 |